| Miss Fafa Tsikata, ATC | |
|
428 Orchard Ave, Yeadon, PA 19050-3114 | |
| (484) 343-0260 | |
| Not Available |
| Full Name | Miss Fafa Tsikata |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Sports Medicine |
| Location | 428 Orchard Ave, Yeadon, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285161604 | NPI | - | NPPES |
| 200005221 | Other | BOARD OF CERTIFICATION | |
| RT005186 | Other | PA | PENNSYLVANIA BOARD OF MEDICINE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | RT005186 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Fafa Tsikata, ATC 113 N Front St, Lewisburg, PA 17837-1507 Ph: (484) 343-0260 | Miss Fafa Tsikata, ATC 428 Orchard Ave, Yeadon, PA 19050-3114 Ph: (484) 343-0260 |
News Archive
Two recent experimental treatments - one involving skin-derived induced pluripotent stem (iPS) cell grafts, the other gene therapy - have been shown to produce long-term improvement in visual function in mouse models of retinitis pigmentosa (RP), according to the Columbia University Medical Center (CUMC) scientists who led the studies. At present, there is no cure for RP, the most common form of inherited blindness.
Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows. The implant and extension took place at Texas Children's Cancer Center in Houston, Texas.
The mechanisms by which obesity leads towards metabolic co-morbidities, such as diabetes mellitus, are poorly understood and of great public health interest. A study led by Matej Orešič from VTT Technical Research Centre of Finland suggests that adaptation of fat cell membranes to obesity may play a key role in the early stages of inflammatory disorders.
Bohai Pharmaceuticals Group, Inc., a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announced the introduction of five additional pharmaceutical products to its portfolio of TCM offerings.
› Verified 7 days ago